Mitchell Mutz

Director at Bonum Therapeutics.

Raised on Bonum Therapeutics filings

$26.9M

of $32.3M offered across 1 Form D filing

Form D filings: 1
Teammates: 10
Last filing: Apr 17, 2026

Company

Bonum Therapeutics

Biotech · Seattle, WA

Cytokine therapies that switch on only at their target

Cytokine therapies that switch on only at their target

Investors: 8
Founded: 2021
Still open: $5.4M

Investors: 8
Sector: Biotech
Founded: 2021
HQ: Seattle, WA

Bonum Therapeutics filings

Bonum Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Apr 17, 2026	Equity	$26.9M/ $32.3M	Form D

EquityFiled Apr 17, 2026Form D
$26.9M/ $32.3M

Works with

Also named on Bonum Therapeutics filings

John MulliganChief Executive Officer, Form D signerForm D signer Samuel BlackmanDirector Diane HollenbaughExecutive Officer Gaurav AggarwalDirector John McKearnDirector Karl HandelsmanDirector Monique SchiersingDirector Neela PatelExecutive Officer Nicholas WalrodDirector Samuel BjorkDirector